Felipe Vilardell Villellas
Grau: Doctor/a
fvilardell.lleida.ics(ELIMINAR)@gencat.cat
ResearcherID: http://www.researcherid.com/rid/B-8141-2015
Grups
Publicacions
-
Navarro-Masip, E; Petit, NM; Salinas-Roca, B; Herrerías, F; VILARDELL, F; de la Fuente, MC; Pallares, J; Santamaría, M; Zorzano-Martínez, M; Sánchez, E; Matías-Guiu, X; López-Cano, C; Soler, AG; León-Mengíbar, J; Bueno, M; Lecube, A
Metabolic Dysfunction-Associated Steatotic Liver Disease in Severe Obesity and Concordance between Invasive (Biopsy) and Noninvasive (OWLiver®) Diagnoses
Obesity Facts 17 473-482. .
-
León-Mengibar, J; Sánchez, E; Herrerías, F; de la Fuente, MC; Santamaría, M; Valdivielso, JM; Bermúdez-López, M; Castro, E; Pallarés, J; Matias-Guiu, X; VILARDELL, F; Caixàs, A; Bueno, M; Marti, R; Lecube, A
Influence of nonalcoholic fatty liver disease severity on carotid adventitial vasa vasorum
Frontiers in Endocrinology 15 1366015-1366015. .
-
Samain, R; Maiques, O; Monger, J; Lam, H; Candido, J; George, S; Ferrari, N; Kohihammer, L; Lunetto, S; Varela, A; Orgaz, JL; VILARDELL, F; Olsina, JJ; Matias-Guiu, X; Sarker, D; Biddle, A; Balkwill, FR; Eyles, J; Wilkinson, RW; Kocher, HM; Calvo, F; Wells, CM; Sanz-Moreno, V
CD73 controls Myosin II-driven invasion, metastasis, and immunosuppression in amoeboid pancreatic cancer cells
Science Advances 9 -. .
-
Huerva V; Vilardell F; Cid-Bertomeu P
Cryotherapy after Topical Interferon Alpha 2b to Treat Conjunctival Primary Acquired Melanosis.
Case Reports In Ophthalmology 14 111-114. .
-
Canal-Garcia E; Soria X; Vilardell F; Marti RM
Acral reed nevus with parallel ridge pattern: an exception to the rule of malignancy.
ANAIS BRASILEIROS DE DERMATOLOGIA 98 246-248. .
-
Alturo-Pons A; Alamon-Reig F; Sanmartin Novell V; Vilardell F; Martí RM
[[Translated article]]Congenital and Acquired Epidermodysplasia Verruciformis: A Series of 7 Cases.
ACTAS DERMO-SIFILIOGRAFICAS 114 179-182. .
-
Matas-Nadal C; Soria X; Gonzalez-Farré M; Baradad M; Tuset N; Rius Riu F; González M; Gatius S; Vilardell F; López-Ortega R; María Martí R
Abdominal tumors in patients with neurofibromatosis type I: Genotype-phenotype relationships.
European Journal of Medical Genetics 65 104609-104609. .
-
Alturo-Pons A; Alamon-Reig F; Sanmartin Novell V; Vilardell F; Martí RM
Congenital and Acquired Epidermodysplasia Verruciformis: A Series of 7 Cases.
ACTAS DERMO-SIFILIOGRAFICAS 114 179-182. .
-
Vilaltella, M; Vilardell, F; Cid-Bertomeu, P; Huerva, V
IgG(4)-related orbital disease
CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE 57 78-79. .
-
Belokopytova-Chakh, A; Ruiz-Gonzalez, A; Vilardell-Vilellas, F; Porcel, JM
Cardiac tamponade as the initial presentation of a T-cell lymphoblastic lymphoma
Galicia Clinica 83 42-44. .
-
Soria X; Vilardell F; Maiques Ó; Barceló C; Sisó P; de la Rosa I; Velasco A; Cuevas D; Santacana M; Gatius S; Matías-Guiu X; Rodrigo A; Macià A; Martí RM
BRAF(V600E)
Mutant Allele Frequency (MAF) Influences Melanoma Clinicopathologic Characteristics
Cancers 13 -. .
-
Vieites, B; Lopez-Garcia, MA; Martin-Salvago, MD; Ramirez-Tortosa, CL; Rezola, R; de Salas, MS; Vilaro, LL; Villellas, FV; Burgues, O; Fernandez-Rodriguez, B; Galan, LA; Peg, V
Patient follow-up of NEOVATTL study
ANNALS OF ONCOLOGY 32 49-49. .
Projectes
- Simultaneous targeting the partners in crime MYC and BRD4 in triple negative breast cancer
- Análisis del microambiente tumoral del melanoma cutáneo asociado al perfil genético y/o a la aparición de resistencias
- Development of precision therapies for triple negative breast cancer based on CRISPR/Cas12a ribonucleoproteins
- Análisis del secretoma en el melanoma humano asociado al perfil genético y a la aparición de resistencias. Identificación de biomarcadores y/o dianas terapéuticas de aplicación clínica
- POSTDOCTORAL AECC 2017: ESTUDIO DE LA HETEROGENEIDAD TUMORAL EN EL MELANOMA HUMANO. ESTUDIO DE LAS RESISTENCIAS A FARMACOS CONVENCIONALES Y EL PROCESO AUTOFAGICO
- ESTUDIO DE LA HETEROGENEIDAD TUMORAL EN EL MELANOMA
- Carcinoma de endometrio. Participación de las vías de señalización, implicadas en la resistencia a la terapia antineoplasica
- CONTRATOS POSTDOCTORALES DE PERFECCIONAMIENTO SARA BORRELL